GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BRAIN Biotech AG (CHIX:BNNd) » Definitions » PB Ratio

BRAIN Biotech AG (CHIX:BNND) PB Ratio : 6.96 (As of Jun. 23, 2024)


View and export this data going back to 2018. Start your Free Trial

What is BRAIN Biotech AG PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-23), BRAIN Biotech AG's share price is €5.86. BRAIN Biotech AG's Book Value per Share for the quarter that ended in Mar. 2024 was €0.84. Hence, BRAIN Biotech AG's PB Ratio of today is 6.96.

Good Sign:

BRAIN Biotech AG stock PB Ratio (=3.23) is close to 10-year low of 3.22

The historical rank and industry rank for BRAIN Biotech AG's PB Ratio or its related term are showing as below:

CHIX:BNNd' s PB Ratio Range Over the Past 10 Years
Min: 3.22   Med: 8.21   Max: 24.64
Current: 3.23

During the past 9 years, BRAIN Biotech AG's highest PB Ratio was 24.64. The lowest was 3.22. And the median was 8.21.

CHIX:BNNd's PB Ratio is ranked worse than
79.11% of 1532 companies
in the Chemicals industry
Industry Median: 1.575 vs CHIX:BNNd: 3.23

During the past 12 months, BRAIN Biotech AG's average Book Value Per Share Growth Rate was -26.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -1.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 1.70% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of BRAIN Biotech AG was 45.40% per year. The lowest was -26.30% per year. And the median was 4.60% per year.

Back to Basics: PB Ratio


BRAIN Biotech AG PB Ratio Historical Data

The historical data trend for BRAIN Biotech AG's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BRAIN Biotech AG PB Ratio Chart

BRAIN Biotech AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
PB Ratio
Get a 7-Day Free Trial Premium Member Only 13.94 6.83 5.63 4.32 5.88

BRAIN Biotech AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.10 5.49 5.88 6.65 6.96

Competitive Comparison of BRAIN Biotech AG's PB Ratio

For the Specialty Chemicals subindustry, BRAIN Biotech AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BRAIN Biotech AG's PB Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, BRAIN Biotech AG's PB Ratio distribution charts can be found below:

* The bar in red indicates where BRAIN Biotech AG's PB Ratio falls into.



BRAIN Biotech AG PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

BRAIN Biotech AG's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=5.86/0.842
=6.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


BRAIN Biotech AG  (CHIX:BNNd) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


BRAIN Biotech AG PB Ratio Related Terms

Thank you for viewing the detailed overview of BRAIN Biotech AG's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BRAIN Biotech AG (CHIX:BNND) Business Description

Traded in Other Exchanges
Address
Darmstadter Strasse 34-36, Zwingenberg, BW, DEU, 64673
BRAIN Biotech AG is a technology company in the field of industrial biotechnology. It serves the chemical and consumer goods industries. The company develops novel biological ingredients such as enzymes, biocatalysts, and bioactive natural compounds. The company's segments include, BioProducts, BioScience and BioIncubator. Majority of the revenue is generated from its BioProducts segment which comprises of the product business with enzymes and other proteins for specific segments of the food industry. Geographically, the company generates majority of the revenue from United States of America and also has presence in other markets such as, Germany, France, United Kingdom and Netherlands.

BRAIN Biotech AG (CHIX:BNND) Headlines

No Headlines